NCT01375140 2025-06-08Ruxolitinib and Lenalidomide for Patients With MyelofibrosisM.D. Anderson Cancer CenterPhase 2 Completed31 enrolled 8 charts
NCT00227591 2014-05-21Lenalidomide and Prednisone in Treating Patients With MyelofibrosisNational Cancer Institute (NCI)Phase 2 Completed48 enrolled 7 charts
NCT00445900 2011-03-17Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid MetaplasiaMayo ClinicPhase 2 Completed22 enrolled